Novel antifungal drug shows promise in some patients with Valley Fever
A subanalysis of a single-group, open-label, Phase IIb study found that olorofim, a first-in-class orotomide antifungal agent that does not have U.S. FDA approval, showed efficacy in patients with disseminated coccidioidomycosis ...
Jul 20, 2026
0
3
